{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:09:21Z","timestamp":1790453361204,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":145,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811072291","type":"print"},{"value":"9789811072307","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-10-7230-7_13","type":"book-chapter","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T10:29:29Z","timestamp":1528799369000},"page":"271-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Vaccine Development for Cytomegalovirus"],"prefix":"10.1007","author":[{"given":"Naoki","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"13_CR1","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/JVI.00883-10","volume":"85","author":"K Abel","year":"2011","unstructured":"Abel K, Martinez J, Yue Y et al (2011) Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques. J Virol 85:2878\u20132890","journal-title":"J Virol"},{"key":"13_CR2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcv.2007.11.008","volume":"41","author":"SP Adler","year":"2008","unstructured":"Adler SP (2008) Human CMV vaccine trials: what if CMV caused a rash? J Clin Virol 41:231\u2013236","journal-title":"J Clin Virol"},{"key":"13_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/171.1.26","volume":"171","author":"SP Adler","year":"1995","unstructured":"Adler SP, Starr SE, Plotkin SA et al (1995) Immunity induced by primary human cytomegalovirus-infection protects against secondary infection among women of childbearing age. J Infect Dis 171:26\u201332","journal-title":"J Infect Dis"},{"key":"13_CR4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/314951","volume":"180","author":"SP Adler","year":"1999","unstructured":"Adler SP, Plotkin SA, Gonczol E et al (1999) A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). J Infect Dis 180:843\u2013846","journal-title":"J Infect Dis"},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/infdis\/jiw365","volume":"214","author":"SP Adler","year":"2016","unstructured":"Adler SP, Manganello AM, Lee R et al (2016) A phase 1 study of 4 live, recombinant human cytomegalovirus Towne\/Toledo chimera vaccines in cytomegalovirus-seronegative men. J Infect Dis 214:1341\u20131348","journal-title":"J Infect Dis"},{"key":"13_CR132","doi-asserted-by":"crossref","unstructured":"Adler S, Lewis N, Conlon A et al (2017) Phase 1 clinical trial of a replication-defective human cytomegalovirus (CMV) vaccine. ID Week 2017 presentation","DOI":"10.1093\/ofid\/ofx163.718"},{"key":"13_CR6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1756-0500-5-140","volume":"5","author":"R Arav-Boger","year":"2012","unstructured":"Arav-Boger R, Wojcik GL, Duggal P et al (2012) Polymorphisms in toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine. BMC Res Notes 5:140","journal-title":"BMC Res Notes"},{"key":"13_CR7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/421999","volume":"39","author":"AM Arvin","year":"2004","unstructured":"Arvin AM, Fast P, Myers M et al (2004) Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis 39:233\u2013239","journal-title":"Clin Infect Dis"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"9310","DOI":"10.1128\/JVI.00162-14","volume":"88","author":"BT Assaf","year":"2014","unstructured":"Assaf BT, Mansfield KG, Strelow L et al (2014) Limited dissemination and shedding of the UL128 complex-intact, UL\/b\u2019-defective rhesus cytomegalovirus strain 180.92. J Virol 88:9310\u20139320","journal-title":"J Virol"},{"key":"13_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004060","volume":"10","author":"MR Auerbach","year":"2014","unstructured":"Auerbach MR, Yan D, Vij R et al (2014) A neutralizing anti-gH\/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection. PLoS Pathog 10:e1004060","journal-title":"PLoS Pathog"},{"key":"13_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ilar.47.1.49","volume":"47","author":"PA Barry","year":"2006","unstructured":"Barry PA, Lockridge KM, Salamat S et al (2006) Nonhuman primate models of intrauterine cytomegalovirus infection. ILAR J 47:49\u201364","journal-title":"ILAR J"},{"key":"13_CR11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/319680","volume":"183","author":"K Berencsi","year":"2001","unstructured":"Berencsi K, Gyulai Z, G\u00f6ncz\u00f6l E et al (2001) A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects. J Infect Dis 183:1171\u20131179","journal-title":"J Infect Dis"},{"key":"13_CR12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","volume":"28","author":"DI Bernstein","year":"2009","unstructured":"Bernstein DI, Reap EA, Katen K et al (2009) Randomized, double-blind, phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. Vaccine 28:484\u2013493","journal-title":"Vaccine"},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","volume":"34","author":"DI Bernstein","year":"2016","unstructured":"Bernstein DI, Munoz FM, Callahan ST et al (2016) Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial. Vaccine 34:313\u2013319","journal-title":"Vaccine"},{"key":"13_CR14","doi-asserted-by":"crossref","first-page":"13645","DOI":"10.1073\/pnas.1511526112","volume":"112","author":"KM Bialas","year":"2015","unstructured":"Bialas KM, Tanaka T, Tran D et al (2015) Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission. Proc Natl Acad Sci U S A 112:13645\u201313650","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/171.5.1115","volume":"171","author":"SB Boppana","year":"1995","unstructured":"Boppana SB, Britt WJ (1995) Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 171:1115\u20131121","journal-title":"J Infect Dis"},{"issue":"15","key":"13_CR133","first-page":"e02392","volume":"91","author":"William J. Britt","year":"2017","unstructured":"Britt WJ (2017) Congenital human cytomegalovirus infection and the enigma of maternal immunity. J Virol 91:e02392-16","journal-title":"Journal of Virology"},{"key":"13_CR16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20042384","volume":"201","author":"T Bunde","year":"2005","unstructured":"Bunde T, Kirchner A, Hoffmeister B et al (2005) Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 201:1031\u20131036","journal-title":"J Exp Med"},{"key":"13_CR17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006014","volume":"12","author":"BJ Burwitz","year":"2016","unstructured":"Burwitz BJ, Malouli D, Bimber BN et al (2016) Cross-species rhesus cytomegalovirus infection of cynomolgus macaques. PLoS Pathog 12:e1006014","journal-title":"PLoS Pathog"},{"key":"13_CR18","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2016.03.005","volume":"34","author":"RD Cardin","year":"2016","unstructured":"Cardin RD, Bravo FJ, Pullum DA et al (2016) Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection. Vaccine 34:1993\u20131999","journal-title":"Vaccine"},{"key":"13_CR19","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1128\/JVI.01554-13","volume":"87","author":"C Cayatte","year":"2013","unstructured":"Cayatte C, Schneider-Ohrum K, Wang Z et al (2013) Cytomegalovirus vaccine strain Towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells. J Virol 87:11107\u201311120","journal-title":"J Virol"},{"key":"13_CR20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/JVI.70.1.78-83.1996","volume":"70","author":"TA Cha","year":"1996","unstructured":"Cha TA, Tom E, Kemble GW et al (1996) Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70:78\u201383","journal-title":"J Virol"},{"issue":"12","key":"13_CR134","doi-asserted-by":"crossref","first-page":"eaan1457","DOI":"10.1126\/sciimmunol.aan1457","volume":"2","author":"Sumana Chandramouli","year":"2017","unstructured":"Chandramouli S, Malito E, Nguyen T et al (2017) Structural basis for potent antibody-mediated neutralization of human cytomegalovirus. Sci Immunol 2:eaan1457","journal-title":"Science Immunology"},{"key":"13_CR21","doi-asserted-by":"crossref","first-page":"22647","DOI":"10.1073\/pnas.1013794108","volume":"107","author":"WLW Chang","year":"2010","unstructured":"Chang WLW, Barry PA (2010) Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity. Proc Natl Acad Sci U S A 107:22647\u201322652","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR22","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1128\/JVI.78.16.8720-8731.2004","volume":"78","author":"WL Chang","year":"2004","unstructured":"Chang WL, Baumgarth N, Yu D, Barry PA (2004) Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J Virol 78:8720\u20138731","journal-title":"J Virol"},{"key":"13_CR23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/320714","volume":"183","author":"A Chatterjee","year":"2001","unstructured":"Chatterjee A, Harrison CJ, Britt WJ, Bewtra C (2001) Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs. J Infect Dis 183:1547\u20131553","journal-title":"J Infect Dis"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.placenta.2009.09.001","volume":"30","author":"S Chaudhuri","year":"2009","unstructured":"Chaudhuri S, Lowen B, Chan G et al (2009) Human cytomegalovirus interacts with toll-like receptor 2 and CD14 on syncytiotrophoblasts to stimulate expression of TNF\u03b1 mRNA and apoptosis. Placenta 30:994\u20131001","journal-title":"Placenta"},{"key":"13_CR25","doi-asserted-by":"crossref","first-page":"11884","DOI":"10.1128\/JVI.01701-15","volume":"89","author":"F Chiuppesi","year":"2015","unstructured":"Chiuppesi F, Wussow F, Johnson E et al (2015) Vaccine-derived neutralizing antibodies to the human cytomegalovirus gH\/gL pentamer potently block primary cytotrophoblast infection. J Virol 89:11884\u201311898","journal-title":"J Virol"},{"key":"13_CR26","doi-asserted-by":"crossref","first-page":"e01857","DOI":"10.1128\/JVI.01857-16","volume":"91","author":"F Chiuppesi","year":"2017","unstructured":"Chiuppesi F, Kaltcheva T, Meng Z et al (2017) Identification of a continuous neutralizing epitope within UL128 of human cytomegalovirus. J Virol 91:e01857\u2013e01816","journal-title":"J Virol"},{"key":"13_CR27","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1073\/pnas.1424818112","volume":"112","author":"C Ciferri","year":"2015","unstructured":"Ciferri C, Chandramouli S, Donnarumma D et al (2015a) Structural and biochemical studies of HCMV gH\/gL\/gO and Pentamer reveal mutually exclusive cell entry complexes. Proc Natl Acad Sci U S A 112:1767\u20131772","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005230","volume":"11","author":"C Ciferri","year":"2015","unstructured":"Ciferri C, Chandramouli S, Leitner A et al (2015b) Antigenic characterization of the HCMV gH\/gL\/gO and Pentamer cell entry complexes reveals binding sites for potently neutralizing human antibodies. PLoS Pathog 11:e1005230","journal-title":"PLoS Pathog"},{"key":"13_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/421496","volume":"39","author":"A Coaquette","year":"2004","unstructured":"Coaquette A, Bourgeois A, Dirand C et al (2004) Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 39:155\u2013161","journal-title":"Clin Infect Dis"},{"key":"13_CR30","doi-asserted-by":"crossref","first-page":"e1004131","DOI":"10.1371\/journal.ppat.1004131","volume":"10","author":"E Corrales-Aguilar","year":"2014","unstructured":"Corrales-Aguilar E, Trilling M, Hunold K et al (2014) Human cytomegalovirus Fc\u03b3 binding proteins gp34 and gp68 antagonize Fc\u03b3 receptors I, II and III. PLoS Pathog 10:e1004131","journal-title":"PLoS Pathog"},{"key":"13_CR31","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1016\/j.vaccine.2009.04.036","volume":"27","author":"MM Crumpler","year":"2009","unstructured":"Crumpler MM, Choi KY, McVoy MA, Schleiss MR (2009) A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine\/challenge model of congenital cytomegalovirus infection. Vaccine 27:4209\u20134218","journal-title":"Vaccine"},{"key":"13_CR32","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2008.07.092","volume":"26","author":"X Cui","year":"2008","unstructured":"Cui X, Meza BP, Adler SP, McVoy MA (2008) Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection. Vaccine 26:5760\u20135766","journal-title":"Vaccine"},{"key":"13_CR33","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1016\/j.vaccine.2012.04.011","volume":"30","author":"AF Dempsey","year":"2012","unstructured":"Dempsey AF, Pangborn HM, Prosser LA (2012) Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus. Vaccine 30:4060\u20134066","journal-title":"Vaccine"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1586\/erv.12.129","volume":"11","author":"LK Dropulic","year":"2012","unstructured":"Dropulic LK, Cohen JI (2012) The challenge of developing a herpes simplex virus 2 vaccine. Expert Rev Vaccines 11:1429\u20131440","journal-title":"Expert Rev Vaccines"},{"key":"13_CR35","doi-asserted-by":"crossref","first-page":"11323","DOI":"10.1128\/JVI.01925-13","volume":"87","author":"MK Eberhardt","year":"2013","unstructured":"Eberhardt MK, Deshpande A, Chang WLW et al (2013) Vaccination against a virus-encoded cytokine significantly restricts viral challenge. J Virol 87:11323\u201311331","journal-title":"J Virol"},{"issue":"9","key":"13_CR36","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1128\/JVI.77.9.5226-5240.2003","volume":"77","author":"R. Elkington","year":"2003","unstructured":"Elkington R, Walker S, Crough T et al (2003) Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 77:5226\u20135240","journal-title":"Journal of Virology"},{"key":"13_CR37","doi-asserted-by":"crossref","unstructured":"Fan Q, Nelson CS, Bialas KM et al (2017) Plasmablast response to primary rhesus cytomegalovirus infection in a monkey model of congenital CMV transmission. Clin Vaccine Immunol 24:e00510-16","DOI":"10.1128\/CVI.00510-16"},{"issue":"10","key":"13_CR142","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/cid\/cix622","volume":"65","author":"Chiara Fornara","year":"2017","unstructured":"Fornara C, Cassaniti I, Zavattoni M et al (2017) Human cytomegalovirus-specific memory CD4+ T-Cell response and its correlation with virus transmission to the fetus in pregnant women with primary infection. Clin Infect Dis 65:1659\u20131665","journal-title":"Clinical Infectious Diseases"},{"key":"13_CR38","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.00467-12","volume":"86","author":"AE Fouts","year":"2012","unstructured":"Fouts AE, Chan P, Stephan J-PP et al (2012) Antibodies against the gH\/gL\/UL128\/UL130\/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin. J Virol 86:7444\u20137447","journal-title":"J Virol"},{"key":"13_CR39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","volume":"326","author":"KB Fowler","year":"1992","unstructured":"Fowler KB, Stagno S, Pass RF et al (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326:663\u2013667","journal-title":"N Engl J Med"},{"key":"13_CR40","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.289.8.1008","volume":"289","author":"KB Fowler","year":"2003","unstructured":"Fowler KB, Stagno S, Pass RF (2003) Maternal immunity and prevention of congenital cytomegalovirus infection. J Am Med Assoc 289:1008\u20131011","journal-title":"J Am Med Assoc"},{"key":"13_CR41","doi-asserted-by":"crossref","first-page":"E4997","DOI":"10.1073\/pnas.1316517110","volume":"110","author":"DC Freed","year":"2013","unstructured":"Freed DC, Tang Q, Tang A et al (2013) Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine. Proc Natl Acad Sci U S A 110:E4997\u2013E5005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR42","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1016\/j.vaccine.2012.10.053","volume":"30","author":"TM Fu","year":"2012","unstructured":"Fu TM, Wang D, Freed DC et al (2012) Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus. Vaccine 30:7469\u20137474","journal-title":"Vaccine"},{"key":"13_CR43","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/AAC.00134-08","volume":"52","author":"Y Fukui","year":"2008","unstructured":"Fukui Y, Shindoh K, Yamamoto Y et al (2008) Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay. Antimicrob Agents Chemother 52:2420\u20132427","journal-title":"Antimicrob Agents Chemother"},{"key":"13_CR44","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/vir.0.83523-0","volume":"89","author":"G Gerna","year":"2008","unstructured":"Gerna G, Sarasini A, Patrone M et al (2008) Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial\/epithelial cells, but not fibroblasts, early during primary infection. J Gen Virol 89:853\u2013865","journal-title":"J Gen Virol"},{"key":"13_CR45","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.vaccine.2014.05.011","volume":"32","author":"PA Gillis","year":"2014","unstructured":"Gillis PA, Hernandez-Alvarado N, Gnanandarajah JS et al (2014) Development of a novel, guinea pig-specific IFN-gamma ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine. Vaccine 32:3963\u20133970","journal-title":"Vaccine"},{"key":"13_CR46","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","volume":"377","author":"PD Griffiths","year":"2011","unstructured":"Griffiths PD, Stanton A, McCarrell E et al (2011) Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 377:1256\u20131263","journal-title":"Lancet"},{"key":"13_CR47","first-page":"e02033","volume":"91","author":"S Ha","year":"2017","unstructured":"Ha S, Li F, Troutman MC et al (2017) Neutralization of diverse human cytomegalovirus strains conferred by antibodies targets viral gH\/gL\/pUL128-131 pentameric complex. J Virol 91:e02033\u2013e02016","journal-title":"J Virol"},{"key":"13_CR48","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1128\/JVI.78.18.10023-10033.2004","volume":"78","author":"G Hahn","year":"2004","unstructured":"Hahn G, Revello MG, Patrone M et al (2004) Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78:10023\u201310033","journal-title":"J Virol"},{"key":"13_CR49","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1128\/JVI.77.12.6620-6636.2003","volume":"77","author":"SG Hansen","year":"2003","unstructured":"Hansen SG, Strelow LI, Franchi DC et al (2003) Complete sequence and genomic analysis of rhesus cytomegalovirus. J Virol 77:6620\u20136636","journal-title":"J Virol"},{"key":"13_CR50","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.vaccine.2013.04.078","volume":"31","author":"K Hashimoto","year":"2013","unstructured":"Hashimoto K, Yamada S, Katano H et al (2013) Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta. Vaccine 31:3199\u20133205","journal-title":"Vaccine"},{"key":"13_CR51","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/503365","volume":"193","author":"TC Heineman","year":"2006","unstructured":"Heineman TC, Schleiss M, Bernstein DI et al (2006) A phase 1 study of 4 live, recombinant human cytomegalovirus Towne\/Toledo chimeric vaccines. J Infect Dis 193:1350\u20131360","journal-title":"J Infect Dis"},{"key":"13_CR52","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcv.2013.07.004","volume":"58","author":"K Ikuta","year":"2013","unstructured":"Ikuta K, Minematsu T, Inoue N et al (2013) Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers. J Clin Virol 58:474\u2013478","journal-title":"J Clin Virol"},{"key":"13_CR53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/518571","volume":"45","author":"K Ishibashi","year":"2007","unstructured":"Ishibashi K, Tokumoto T, Tanabe K et al (2007) Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes. Clin Infect Dis 45:60\u201367","journal-title":"Clin Infect Dis"},{"key":"13_CR54","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.vaccine.2009.01.006","volume":"27","author":"MA Jacobson","year":"2009","unstructured":"Jacobson MA, Adler SP, Sinclair E et al (2009) A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain). Vaccine 27:1540\u20131548","journal-title":"Vaccine"},{"key":"13_CR55","doi-asserted-by":"crossref","first-page":"17965","DOI":"10.1073\/pnas.1415310111","volume":"111","author":"A Kabanova","year":"2014","unstructured":"Kabanova A, Perez L, Lilleri D et al (2014) Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies. Proc Natl Acad Sci U S A 111:17965\u201317970","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR56","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/infdis\/jir819","volume":"205","author":"SH Kang","year":"2012","unstructured":"Kang SH, Abdel-Massih RC, Brown RA et al (2012) Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation. J Infect Dis 205:639\u2013646","journal-title":"J Infect Dis"},{"key":"13_CR57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.micinf.2006.11.004","volume":"9","author":"H Katano","year":"2007","unstructured":"Katano H, Sato Y, Tsutsui Y et al (2007) Pathogenesis of cytomegalovirus-associated labyrinthitis in a guinea pig model. Microbes Infect 9:183\u2013191","journal-title":"Microbes Infect"},{"key":"13_CR58","first-page":"5","volume":"53","author":"P Kaufmann","year":"1977","unstructured":"Kaufmann P, Davidoff M (1977) The guinea-pig placenta. Adv Anat Embryol Cell Biol 53:5\u201391","journal-title":"Adv Anat Embryol Cell Biol"},{"issue":"4","key":"13_CR141","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","volume":"17","author":"Aileen Kenneson","year":"2007","unstructured":"Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253\u2013276","journal-title":"Reviews in Medical Virology"},{"key":"13_CR59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","volume":"12","author":"MA Kharfan-Dabaja","year":"2012","unstructured":"Kharfan-Dabaja MA, Boeckh M, Wilck MB et al (2012) A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 12:290\u2013299","journal-title":"Lancet Infect Dis"},{"key":"13_CR60","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/CVI.00662-13","volume":"21","author":"M Kirchmeier","year":"2014","unstructured":"Kirchmeier M, Fluckiger AC, Soare C et al (2014) Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity. Clin Vaccine Immunol 21:174\u2013180","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"13_CR135","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1086\/598506","volume":"48","author":"Shin Koyano","year":"2009","unstructured":"Koyano S, Inoue N, Nagamori T et al (2009) Dried umbilical cords in the retrospective diagnosis of congenital cytomegalovirus infection as a cause of developmental delays. Clin Infect Dis 48:e93\u2013e95","journal-title":"Clinical Infectious Diseases"},{"key":"13_CR61","doi-asserted-by":"crossref","first-page":"e000118","DOI":"10.1136\/bmjopen-2011-000118","volume":"1","author":"S Koyano","year":"2011","unstructured":"Koyano S, Inoue N, Oka A et al (2011) Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open 1:e000118","journal-title":"BMJ Open"},{"key":"13_CR62","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.vaccine.2013.09.042","volume":"32","author":"PR Krause","year":"2013","unstructured":"Krause PR, Bialek SR, Boppana SB et al (2013) Priorities for CMV vaccine development. Vaccine 32:4\u201310","journal-title":"Vaccine"},{"key":"13_CR63","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/infdis\/jis107","volume":"205","author":"C Rosa La","year":"2012","unstructured":"La Rosa C, Longmate J, Lacey SF et al (2012) Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant. J Infect Dis 205:1294\u20131302","journal-title":"J Infect Dis"},{"key":"13_CR64","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1182\/blood-2016-07-729756","volume":"129","author":"C Rosa La","year":"2017","unstructured":"La Rosa C, Longmate J, Martinez J et\u00a0al (2017) MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults. Blood 129:114\u2013125","journal-title":"Blood"},{"key":"13_CR65","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/507634","volume":"43","author":"R Torre La","year":"2006","unstructured":"La Torre R, Nigro G, Mazzocco M et al (2006) Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 43:994\u20131000","journal-title":"Clin Infect Dis"},{"key":"13_CR66","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1086\/508495","volume":"194","author":"SF Lacey","year":"2006","unstructured":"Lacey SF, La Rosa C, Zhou W et al (2006) Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients. J Infect Dis 194:1410\u20131421","journal-title":"J Infect Dis"},{"key":"13_CR67","doi-asserted-by":"crossref","first-page":"e1004881","DOI":"10.1371\/journal.ppat.1004881","volume":"11","author":"I Landais","year":"2015","unstructured":"Landais I, Pelton C, Streblow D et al (2015) Human cytomegalovirus miR-UL112-3p targets TLR2 and modulates the TLR2\/IRAK1\/NF\u03baB signaling pathway. PLoS Pathog 11:e1004881","journal-title":"PLoS Pathog"},{"key":"13_CR68","doi-asserted-by":"crossref","first-page":"906948","DOI":"10.1155\/2013\/906948","volume":"2013","author":"MP Leviton","year":"2013","unstructured":"Leviton MP, Lacayo JC, Choi KY et al (2013) An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model. Clin Dev Immunol 2013:906948","journal-title":"Clin Dev Immunol"},{"key":"13_CR69","doi-asserted-by":"crossref","first-page":"19950","DOI":"10.1073\/pnas.0811063106","volume":"105","author":"AE Lilja","year":"2008","unstructured":"Lilja AE, Shenk T (2008) Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types. Proc Natl Acad Sci U S A 105:19950\u201319955","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR70","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/512245","volume":"195","author":"D Lilleri","year":"2007","unstructured":"Lilleri D, Fornara C, Furione M et al (2007) Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J Infect Dis 195:1062\u20131070","journal-title":"J Infect Dis"},{"key":"13_CR71","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s10875-012-9739-3","volume":"32","author":"D Lilleri","year":"2012","unstructured":"Lilleri D, Kabanova A, Lanzavecchia A, Gerna G (2012) Antibodies against neutralization epitopes of human cytomegalovirus gH\/gL\/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo. J Clin Immunol 32:1324\u20131331","journal-title":"J Clin Immunol"},{"key":"13_CR72","doi-asserted-by":"crossref","first-page":"e0059863","DOI":"10.1371\/journal.pone.0059863","volume":"8","author":"D Lilleri","year":"2013","unstructured":"Lilleri D, Kabanova A, Revello MG et al (2013) Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pUL128-130-131 complex during primary infection. PLoS One 8:e0059863","journal-title":"PLoS One"},{"key":"13_CR73","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.vaccine.2012.12.009","volume":"31","author":"RJ Loomis","year":"2013","unstructured":"Loomis RJ, Lilja AE, Monroe J et\u00a0al (2013) Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies. Vaccine 31:919\u2013926","journal-title":"Vaccine"},{"key":"13_CR74","doi-asserted-by":"crossref","first-page":"15985","DOI":"10.1074\/jbc.M115.652230","volume":"290","author":"JW Loughney","year":"2015","unstructured":"Loughney JW, Rustandi RR, Wang D et al (2015) Soluble human cytomegalovirus gH\/gL\/pUL128-131 pentameric complex, but not gH\/gL, inhibits viral entry to epithelial cells and presents dominant native neutralizing epitopes. J Biol Chem 290:15985\u201315995","journal-title":"J Biol Chem"},{"key":"13_CR75","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","volume":"84","author":"A Macagno","year":"2010","unstructured":"Macagno A, Bernasconi NL, Vanzetta F et al (2010) Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex. J Virol 84:1005\u20131013","journal-title":"J Virol"},{"issue":"4","key":"13_CR76","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2353\/ajpath.2006.050482","volume":"168","author":"Ekaterina Maidji","year":"2006","unstructured":"Maidji E, McDonagh S, Genbacev O et al (2006) Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 168:1210\u20131226","journal-title":"The American Journal of Pathology"},{"key":"13_CR77","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.antiviral.2017.01.024","volume":"140","author":"R Majima","year":"2017","unstructured":"Majima R, Shindoh K, Yamaguchi T, Inoue N (2017) Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62. Antivir Res 140:142\u2013150","journal-title":"Antivir Res"},{"key":"13_CR78","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1128\/JVI.01132-12","volume":"86","author":"D Malouli","year":"2012","unstructured":"Malouli D, Nakayasu ES, Viswanathan K et al (2012) Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1. J Virol 86:8959\u20138973","journal-title":"J Virol"},{"key":"13_CR79","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.1128\/JVI.05840-11","volume":"85","author":"AK Marsh","year":"2011","unstructured":"Marsh AK, Willer DO, Ambagala APN et al (2011) Genomic sequencing and characterization of cynomolgus macaque cytomegalovirus. J Virol 85:12995\u201313009","journal-title":"J Virol"},{"issue":"11","key":"13_CR136","doi-asserted-by":"crossref","first-page":"e0187731","DOI":"10.1371\/journal.pone.0187731","volume":"12","author":"Federico Mele","year":"2017","unstructured":"Mele F, Fornara C, Jarrossay D et al (2017) Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission. PLoS One 12:e0187731","journal-title":"PLOS ONE"},{"key":"13_CR80","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcv.2005.08.011","volume":"35","author":"S McDonagh","year":"2006","unstructured":"McDonagh S, Maidji E, Chang HT, Pereira L (2006) Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis. J Clin Virol 35:210\u2013215","journal-title":"J Clin Virol"},{"issue":"2","key":"13_CR137","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12185-016-2110-3","volume":"105","author":"Takehiko Mori","year":"2016","unstructured":"Mori T, Kanda Y, Takenaka K et al (2017) Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial. Int J Hematol 105:206\u2013212","journal-title":"International Journal of Hematology"},{"key":"13_CR81","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.autrev.2011.10.007","volume":"11","author":"A Nahum","year":"2012","unstructured":"Nahum A, Dadi H, Bates A, Roifman CM (2012) The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity. Autoimmun Rev 11:341\u2013347","journal-title":"Autoimmun Rev"},{"key":"13_CR82","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(15)00246-X","volume":"3","author":"R Nakamura","year":"2016","unstructured":"Nakamura R, Rosa C, La LJ et al (2016) Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial. Lancet Haematol 3:e87\u2013e98","journal-title":"Lancet Haematol"},{"key":"13_CR003","unstructured":"NCT01974206 News release (2016) HP of Vical ( www.vical.com\/investors\/news-releases\/News-Release-Details\/2016\/Vical-and-Astellas-Announce-Topline-Results-from-a-Phase-2-Study-of-Investigational-Cytomegalovirus-CMV-Vaccine-ASP0113-in-Kidney-Transplant-Patients\/default.aspx )"},{"key":"13_CR002","unstructured":"NCT01877655 News release (2017) HP of Vical ( www.vical.com\/investors\/news-releases\/News-Release-Details\/2017\/Vical-Announces-Completion-of-the-Phase-3-ASP0113-CMV-Vaccine-Trial\/default.aspx )"},{"key":"13_CR004","unstructured":"NCT02798692 News release (2017) HP of Hooki ( www.29c5yd3ksizu1pn67922fy74.wpengine.netdna-cdn.com\/wp-content\/uploads\/2017\/05\/Hookipa-press-release-HB-101-Data-at-CMV-Conference-4-May-2017.pdf )"},{"key":"13_CR001","unstructured":"NCT02826798 News release (2017) HP of VBI vacinnes ( www.vbivaccines.com\/wire\/cmv-phase-i-clinical-study-update-may-2017\/ )"},{"key":"13_CR138","doi-asserted-by":"crossref","unstructured":"Nelson CS, Cruz DV, Tran D et al (2017) Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys. JCI Insight 2:94002","DOI":"10.1172\/jci.insight.94002"},{"key":"13_CR83","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1128\/JCM.02502-06","volume":"45","author":"N Nozawa","year":"2007","unstructured":"Nozawa N, Koyano S, Yamamoto Y et al (2007) Real-time PCR assay using specimens on filter disks as a template for detection of cytomegalovirus in urine. J Clin Microbiol 45:1305\u20131307","journal-title":"J Clin Microbiol"},{"key":"13_CR84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virol.2008.06.018","volume":"379","author":"N Nozawa","year":"2008","unstructured":"Nozawa N, Yamamoto Y, Fukui Y et al (2008) Identification of a 1.6 kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture. Virology 379:45\u201354","journal-title":"Virology"},{"key":"13_CR85","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jcv.2009.10.004","volume":"46","author":"N Nozawa","year":"2009","unstructured":"Nozawa N, Fang-Hoover J, Tabata T et al (2009) Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. J Clin Virol 46:S58\u2013S63","journal-title":"J Clin Virol"},{"issue":"6","key":"13_CR139","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1086\/511981","volume":"195","author":"Hiroshi Ogawa","year":"2007","unstructured":"Ogawa H, Suzutani T, Baba Y et al (2007) Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and mutations. J Infect Dis 195:782\u2013788","journal-title":"The Journal of Infectious Diseases"},{"key":"13_CR87","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/315022","volume":"180","author":"RF Pass","year":"1999","unstructured":"Pass RF, Dulieg\u00e8 AM, Boppana S et al (1999) A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J Infect Dis 180:970\u2013975","journal-title":"J Infect Dis"},{"key":"13_CR88","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","volume":"360","author":"RF Pass","year":"2009","unstructured":"Pass RF, Zhang C, Evans A et al (2009) Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 360:1191\u20131199","journal-title":"N Engl J Med"},{"key":"13_CR89","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","volume":"362","author":"KS Peggs","year":"2003","unstructured":"Peggs KS, Verfuerth S, Pizzey A et al (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 362:1375\u20131377","journal-title":"Lancet"},{"key":"13_CR90","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1128\/JVI.74.13.6132-6146.2000","volume":"74","author":"S Pepperl","year":"2000","unstructured":"Pepperl S, M\u00fcnster J, Mach M et al (2000) Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression. J Virol 74:6132\u20136146","journal-title":"J Virol"},{"key":"13_CR91","doi-asserted-by":"crossref","first-page":"13301","DOI":"10.1128\/JVI.77.24.13301-13314.2003","volume":"77","author":"L Pereira","year":"2003","unstructured":"Pereira L, Maidji E, McDonagh S et al (2003) Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J Virol 77:13301\u201313314","journal-title":"J Virol"},{"key":"13_CR92","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1016\/j.vaccine.2010.06.051","volume":"28","author":"TJ Petty","year":"2010","unstructured":"Petty TJ, Todd Callahan S, Chen Q et al (2010) Assessment of parental acceptance of a potential cytomegalovirus vaccine for adolescent females. Vaccine 28:5686\u20135690","journal-title":"Vaccine"},{"key":"13_CR93","first-page":"239","volume":"36","author":"E Puchhammer-Stockl","year":"2006","unstructured":"Puchhammer-Stockl E, Gorzer I (2006) Cytomegalovirus and Epstein-Barr virus subtypes--the search for clinical significance. J ClinVirol 36:239\u2013248","journal-title":"J ClinVirol"},{"key":"13_CR94","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.4049\/jimmunol.173.5.3383","volume":"173","author":"MJ Raftery","year":"2004","unstructured":"Raftery MJ, Wieland D, Gronewald S et al (2004) Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J Immunol 173:3383\u20133391","journal-title":"J Immunol"},{"key":"13_CR95","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1016\/j.vaccine.2007.08.016","volume":"25","author":"EA Reap","year":"2007","unstructured":"Reap EA, Morris J, Dryga SA et al (2007) Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus. Vaccine 25:7441\u20137449","journal-title":"Vaccine"},{"key":"13_CR96","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/498872","volume":"193","author":"MG Revello","year":"2006","unstructured":"Revello MG, Lilleri D, Zavattoni M et al (2006) Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers. J Infect Dis 193:269\u2013276","journal-title":"J Infect Dis"},{"key":"13_CR97","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","volume":"370","author":"MG Revello","year":"2014","unstructured":"Revello MG, Lazzarotto T, Guerra B et al (2014) A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 370:1316\u20131326","journal-title":"N Engl J Med"},{"key":"13_CR98","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","volume":"257","author":"SR Riddell","year":"1992","unstructured":"Riddell SR, Watanabe KS, Goodrich JM et al (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238\u2013241","journal-title":"Science"},{"key":"13_CR99","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1086\/649903","volume":"201","author":"SA Ross","year":"2010","unstructured":"Ross SA, Arora N, Novak Z et al (2010) Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 201:386\u2013389","journal-title":"J Infect Dis"},{"key":"13_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-015-2294-6","volume":"17","author":"JNH Russell","year":"2016","unstructured":"Russell JNH, Marsh AK, Willer DO et al (2016) A novel strain of cynomolgus macaque cytomegalovirus: implications for host-virus co-evolution. BMC Genomics 17:1\u201317","journal-title":"BMC Genomics"},{"key":"13_CR101","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1086\/379839","volume":"188","author":"MR Schleiss","year":"2003","unstructured":"Schleiss MR, Bourne N, Bernstein DI (2003) Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. J Infect Dis 188:1868\u20131874","journal-title":"J Infect Dis"},{"key":"13_CR102","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1086\/382751","volume":"189","author":"MR Schleiss","year":"2004","unstructured":"Schleiss MR, Bourne N, Stroup G et al (2004) Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine. J Infect Dis 189:1374\u20131381","journal-title":"J Infect Dis"},{"key":"13_CR103","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1016\/j.vaccine.2006.06.077","volume":"24","author":"MR Schleiss","year":"2006","unstructured":"Schleiss MR, Stroup G, Pogorzelski K, McGregor A (2006) Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine. Vaccine 24:6175\u20136186","journal-title":"Vaccine"},{"key":"13_CR104","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/511982","volume":"195","author":"MR Schleiss","year":"2007","unstructured":"Schleiss MR, Lacayo JC, Belkaid Y et al (2007) Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. J Infect Dis 195:789\u2013798","journal-title":"J Infect Dis"},{"key":"13_CR105","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.vaccine.2013.07.010","volume":"32","author":"MR Schleiss","year":"2014","unstructured":"Schleiss MR, Choi KY, Anderson J et\u00a0al (2014) Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model. Vaccine 32:2756\u20132762","journal-title":"Vaccine"},{"key":"13_CR106","doi-asserted-by":"crossref","first-page":"9727","DOI":"10.1128\/JVI.01419-15","volume":"89","author":"MR Schleiss","year":"2015","unstructured":"Schleiss MR, Bierle CJ, Swanson EC et al (2015) Vaccination with a live attenuated cytomegalovirus devoid of a protein kinase R inhibitory gene results in reduced maternal viremia and improved pregnancy outcome in a guinea pig congenital infection model. J Virol 89:9727\u20139738","journal-title":"J Virol"},{"key":"13_CR107","first-page":"e00300","volume":"24","author":"MR Schleiss","year":"2017","unstructured":"Schleiss MR, Berka U, Watson E et al (2017) Additive protection against congenital cytomegalovirus conferred by combined glycoprotein B\/pp65 vaccination using a lymphocytic choriomeningitis virus vector. ClinVaccine Immunol 24:e00300\u2013e00316","journal-title":"ClinVaccine Immunol"},{"key":"13_CR108","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1128\/JVI.00463-16","volume":"90","author":"K Schneider-Ohrum","year":"2016","unstructured":"Schneider-Ohrum K, Cayatte C, Liu Y et al (2016) Production of cytomegalovirus dense bodies by scalable bioprocess methods maintains immunogenicity and improves neutralizing antibody titers. J Virol 90:10133\u201310144","journal-title":"J Virol"},{"key":"13_CR109","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/infdis\/jis186","volume":"205","author":"GM Scott","year":"2012","unstructured":"Scott GM, Chow SS, Craig ME et al (2012) Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis 205:1305\u20131310","journal-title":"J Infect Dis"},{"key":"13_CR110","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/94476def-de2e-4a6e-b0c2-2f2d2ccae784","volume":"9","author":"J Siewiera","year":"2013","unstructured":"Siewiera J, El Costa H, Tabiasco J et\u00a0al (2013) Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathog 9:e1003257","journal-title":"PLoS Pathog"},{"key":"13_CR111","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1172\/JCI43961","volume":"120","author":"I Slavuljica","year":"2010","unstructured":"Slavuljica I, Busche A, Babi\u0107 M et al (2010) Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest 120:4532\u20134545","journal-title":"J Clin Invest"},{"key":"13_CR112","volume-title":"Vaccines for the 21st century","author":"KR Stratton","year":"2000","unstructured":"Stratton KR, Durch JS, Lawrence RS (2000) Vaccines for the 21st century. National Academy Press, Washington, DC"},{"key":"13_CR113","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.vaccine.2015.06.019","volume":"33","author":"EC Swanson","year":"2015","unstructured":"Swanson EC, Gillis P, Hernandez-Alvarado N et al (2015) Comparison of monovalent glycoprotein B with bivalent gB\/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against p. Vaccine 33:4013\u20134018","journal-title":"Vaccine"},{"key":"13_CR114","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","volume":"202","author":"A Sylwester","year":"2005","unstructured":"Sylwester A, Mitchell B, Edgar J et\u00a0al (2005) Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202:673\u2013685","journal-title":"J Exp Med"},{"key":"13_CR115","doi-asserted-by":"crossref","first-page":"e1092","DOI":"10.1016\/j.ijid.2013.06.004","volume":"17","author":"R Taniguchi","year":"2013","unstructured":"Taniguchi R, Koyano S, Suzutani T et al (2013) Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV disease. Int J Infect Dis 17:e1092\u2013e1097","journal-title":"Int J Infect Dis"},{"issue":"12","key":"13_CR140","doi-asserted-by":"crossref","first-page":"e1006015","DOI":"10.1371\/journal.ppat.1006015","volume":"12","author":"Adriana Tomi\u0107","year":"2016","unstructured":"Tomi\u0107 A, Varanasi PR, Golemac M et al (2016) Activation of innate and adaptive immunity by a recombinant human cytomegalovirus strain expressing an NKG2D ligand. PLoS Pathog 12:e1006015","journal-title":"PLOS Pathogens"},{"key":"13_CR116","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter EA, Greenberg PD, Gilbert MJ et al (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333:1038\u20131044","journal-title":"N Engl J Med"},{"key":"13_CR117","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","volume":"102","author":"D Wang","year":"2005","unstructured":"Wang D, Shenk T (2005a) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci U S A 102:18153\u201318158","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR118","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1128\/JVI.79.16.10330-10338.2005","volume":"79","author":"D Wang","year":"2005","unstructured":"Wang D, Shenk T (2005b) Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol 79:10330\u201310338","journal-title":"J Virol"},{"key":"13_CR119","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1128\/JVI.78.8.3965-3976.2004","volume":"78","author":"Z Wang","year":"2004","unstructured":"Wang Z, La Rosa C, Maas R et al (2004) Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus. J Virol 78:3965\u20133976","journal-title":"J Virol"},{"key":"13_CR120","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1016\/j.vaccine.2011.09.056","volume":"29","author":"D Wang","year":"2011","unstructured":"Wang D, Li F, Freed DC et al (2011) Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection. Vaccine 29:9075\u20139080","journal-title":"Vaccine"},{"key":"13_CR121","volume":"8","author":"D Wang","year":"2016","unstructured":"Wang D, Freed DC, He X et al (2016) A replication-defective human cytomegalovirus vaccine for prevention of congenital infection. Sci Transl Med 8:362ra145","journal-title":"Sci Transl Med"},{"key":"13_CR122","doi-asserted-by":"crossref","first-page":"13204","DOI":"10.1128\/JVI.05749-11","volume":"85","author":"Y Weisblum","year":"2011","unstructured":"Weisblum Y, Panet A, Zakay-Rones Z et al (2011) Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. J Virol 85:13204\u201313213","journal-title":"J Virol"},{"key":"13_CR123","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.virol.2015.06.023","volume":"485","author":"Y Weisblum","year":"2015","unstructured":"Weisblum Y, Panet A, Zakay-Rones Z et al (2015) Human cytomegalovirus induces a distinct innate immune response in the maternal-fetal interface. Virology 485:289\u2013296","journal-title":"Virology"},{"key":"13_CR124","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.vaccine.2014.05.004","volume":"32","author":"Y Wen","year":"2014","unstructured":"Wen Y, Monroe J, Linton C et al (2014) Human cytomegalovirus gH\/gL\/UL128\/UL130\/UL131A complex elicits potently neutralizing antibodies in mice. Vaccine 32:3796\u20133804","journal-title":"Vaccine"},{"key":"13_CR125","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/JVI.01669-12","volume":"87","author":"F Wussow","year":"2013","unstructured":"Wussow F, Yue Y, Martinez J et\u00a0al (2013) A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques. J Virol 87:1322\u20131332","journal-title":"J Virol"},{"key":"13_CR126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004524","volume":"10","author":"F Wussow","year":"2014","unstructured":"Wussow F, Chiuppesi F, Martinez J et\u00a0al (2014) Human cytomegalovirus vaccine based on the envelope gH\/gL pentamer complex. PLoS Pathog 10:e1004524","journal-title":"PLoS Pathog"},{"key":"13_CR127","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2009.05.034","volume":"391","author":"S Yamada","year":"2009","unstructured":"Yamada S, Nozawa N, Katano H et al (2009) Characterization of the guinea pig cytomegalovirus genome locus that encodes homologs of human cytomegalovirus major immediate-early genes, UL128, and UL130. Virology 391:99\u2013106","journal-title":"Virology"},{"key":"13_CR128","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1099\/vir.0.064527-0","volume":"95","author":"S Yamada","year":"2014","unstructured":"Yamada S, Fukuchi S, Hashimoto K et al (2014) Guinea pig cytomegalovirus GP129\/131\/133, homologues of human cytomegalovirus UL128\/130\/131A, are necessary for infection of monocytes and macrophages. J Gen Virol 95:1376\u20131382","journal-title":"J Gen Virol"},{"key":"13_CR129","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1099\/vir.0.81516-0","volume":"87","author":"Y Yue","year":"2006","unstructured":"Yue Y, Kaur A, Zhou SS, Barry PA (2006) Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65). J Gen Virol 87:777\u2013787","journal-title":"J Gen Virol"},{"key":"13_CR130","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/JVI.01708-06","volume":"81","author":"Y Yue","year":"2007","unstructured":"Yue Y, Kaur A, Eberhardt MK et al (2007) Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques. J Virol 81:1095\u20131109","journal-title":"J Virol"},{"key":"13_CR131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00430-008-0074-5","volume":"197","author":"Y Yue","year":"2008","unstructured":"Yue Y, Wang Z, Abel K et al (2008) Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques. Med Microbiol Immunol 197:117\u2013123","journal-title":"Med Microbiol Immunol"}],"container-title":["Advances in Experimental Medicine and Biology","Human Herpesviruses"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-7230-7_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T11:07:15Z","timestamp":1604401635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-7230-7_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811072291","9789811072307"],"references-count":145,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-7230-7_13","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}